Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion type Assertion NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_head.
- NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion description "[Of the 9 polymorphisms investigated, 7 were associated with breast cancer for BRCA2 carriers (FGFR2, TOX3, MAP3K1, LSP1, 2q35, SLC4A7, 5p12, P = 7 � 10(-11) - 0.03), but only TOX3 and 2q35 were associated with the risk for BRCA1 carriers (P = 0.0049, 0.03, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_provenance.
- NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion evidence source_evidence_literature NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_provenance.
- NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion SIO_000772 21118973 NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_provenance.
- NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion wasDerivedFrom befree-2016 NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_provenance.
- NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_assertion wasGeneratedBy ECO_0000203 NP855898.RA60LFSi-GpV_ELrM7SYOP5b6jgqpZ0ISObHJSdJnJ-_M130_provenance.